Fintel reports that on March 25, 2025, William Blair initiated coverage of Immunic (NasdaqGS:IMUX) with a Outperform ...

Stock analysts at William Blair issued their Q1 2026 earnings per share (EPS) estimates for shares of Neurogene in a research ...

Fintel reports that on March 26, 2025, William Blair initiated coverage of StoneX Group (NasdaqGS:SNEX) with a Outperform ...

William Blair reaffirmed their outperform rating on shares of Huron Consulting Group (NASDAQ:HURN – Free Report) in a ...

Fintel reports that on March 24, 2025, William Blair downgraded their outlook for AZEK (NYSE:AZEK) from Outperform to Market ...

William Blair initiated coverage of StoneX Group (SNEX) with an Outperform rating. StoneX is a diversified specialty brokerage firm with a ...

William Blair restated their outperform rating on shares of Neurogene (NASDAQ:NGNE – Free Report) in a report published on ...

Fintel reports that on March 17, 2025, William Blair upgraded their outlook for DocuSign (NasdaqGS:DOCU) from Market Perform ...

Stock analysts at William Blair increased their Q1 2025 earnings estimates for Boeing in a research report issued on ...

US President Donald Trump has imposed a 25 % tariff on Canada’s steel and aluminium and has threatened sweeping tariffs on ...

Fintel reports that on March 21, 2025, William Blair downgraded their outlook for Valmont Industries (NYSE:VMI) from ...

Research analysts at William Blair initiated coverage on shares of Immunic (NASDAQ:IMUX – Get Free Report) in a research note issued to investors on Tuesday, Marketbeat.com reports. The brokerage set ...